Innovation

New biopolymers

In the global pharmaceutical and medical device industry, HTL has a history of being a long-term innovation partner, making a difference today, and helping to shape tomorrow. By developing new biopolymers for medical applications, HTL expands the range of possibilities and opens doors to new end-products and new benefits.

EXPANDING THE RANGE OF POSSIBILITIES

HTL carries out new biopolymer development from laboratory scale to GMP pilot plant and GMP commercial production.

Biopolymers are produced by biotechnology and can be further functionalized using chemical modifications, including hydrazidation, epoxy grafting, sulfation, silylation, deacetylation and alkylation.

OUR AREAS OF DEVELOPMENT TODAY

Tailor-made Hyaluronic Acid
and Hyaluronan oligosaccharides

New Glycosaminoglycans:
Heparosan
Chondroitin

Functionalized glycosaminoglycan-derivatives:

Hyaluronic Acid derivatives, Heparosan derivatives, Chondroitin derivatives

FROM NEW BIOPOLYMERS TO NEW APPLICATIONS

New biopolymers developed by HTL rely on the benefits of well-known molecules, while introducing new functionalities, brought by molecular weight selection and chemical modification. By creating a new biopolymers offer, HTL intends to bring its customers and partners opportunities of developing new markets.